Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Hospital of Philadelphia
New York Medical College
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Baylor College of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Cellectar Biosciences, Inc.
Centre Oscar Lambret
Children's Oncology Group
Baylor College of Medicine
French Africa Pediatric Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Seattle Children's Hospital
St. Jude Children's Research Hospital
Children's National Research Institute
Mayo Clinic